Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the US.
While clinical manifestations of anti-interferon-γ (IFN-γ) autoantibody-associated immunodeficiency syndrome have been reported, its natural history is not well understood. Clinical data of 74 patients with anti-IFN-γ autoantibodies at Srinagarind Hospital in Thailand were collected at annual follow-up visits (median follow-up duration: 7.5 years). Clinical data at annual follow-up visits for 19 patients and at the initial visit for 4 patients with anti-IFN-γ autoantibodies at the National Institutes of Health in the US were collected by chart review (median follow-up duration: 4.5 years). Anti-IFN-γ autoantibody levels were measured in serial plasma samples. Ninety-one percent of US patients were of Southeast Asian descent and there was a stronger female predominance (91%) in the US than Thailand (64%). M. abscessus (34%) and M. avium complex (83%) were the most commonly isolated nontuberculous mycobacteria in Thailand and the US, respectively. Skin infections were more common in Thailand (P=0.001) whereas bone (P<0.0001), lung (P=0.002), and central nervous system (P=0.03) infections were more common in the US. Twenty-four percent of Thai patients died, mostly from infections. None of the 19 US patients with follow-up data died. Overall, anti-IFN-γ autoantibody levels decreased over time in Thailand (P<0.001) and the US (P=0.017), as well as with cyclophosphamide (P=0.01) and rituximab therapy (P=0.001). Patients with anti-IFN-γ autoantibodies in Thailand and US had distinct demographic and clinical features. While titers generally decreased with time, anti-IFN-γ autoantibody disease has a chronic clinical course with persistent infections and death. Close long-term surveillance for new infections is recommended.